Bivalirudin vs Pentosan Polysulfate
Overview
Bivalirudin is primarily a cardiovascular peptide, while Pentosan Polysulfate is used for healing & recovery.
This page compares Bivalirudin and Pentosan Polysulfate across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Bivalirudin | Pentosan Polysulfate | |
|---|---|---|
| Category | Cardiovascular | Healing & Recovery |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | 0.75 mg/kg IV bolus, then 1.75 mg/kg/h IV infusion | 300 mg |
| Frequency | Single procedural session: bolus immediately before PCI followed by continuous infusion during the procedure; optional post-procedural infusion for up to approximately 20 hours | daily |
| Reported benefits | Anticoagulation during PCI and PTCA, anticoagulation in HIT/HITTS patients undergoing PCI, reduced major bleeding versus heparin plus glycoprotein IIb/IIIa inhibitor, predictable pharmacokinetics without need for antithrombin cofactor, rapid offset of anticoagulation due to short half-life, inhibition of both circulating and clot-bound thrombin | Joint protection, cartilage health, anti-inflammatory, bladder health |
| Reported side effects | Bleeding (most common, including access-site and retroperitoneal), acute stent thrombosis (early, within 24 hours), back pain, nausea, headache, hypotension, injection-site pain, hypersensitivity reactions, thrombocytopenia (rare) | Possible GI upset, hair loss (rare) |
Key differences
Primary use. Bivalirudin is categorised under Cardiovascular, while Pentosan Polysulfate falls under Healing & Recovery. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Bivalirudin: FDA-approved. Pentosan Polysulfate: FDA-approved.
Dosing. Bivalirudin is typically dosed at 0.75 mg/kg IV bolus, then 1.75 mg/kg/h IV infusion (Single procedural session: bolus immediately before PCI followed by continuous infusion during the procedure; optional post-procedural infusion for up to approximately 20 hours). Pentosan Polysulfate is typically dosed at 300 mg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Bivalirudin and Pentosan Polysulfate has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Bivalirudin and Pentosan Polysulfate?
- Bivalirudin is primarily a cardiovascular peptide, while Pentosan Polysulfate is used for healing & recovery. Bivalirudin is FDA-approved for one or more indications, whereas Pentosan Polysulfate is FDA-approved for one or more indications.
- What is Bivalirudin used for?
- FDA-approved synthetic peptide direct thrombin inhibitor used for anticoagulation during PCI, including in HIT patients.
- What is Pentosan Polysulfate used for?
- FDA-approved oral drug (ELMIRON) for bladder pain of interstitial cystitis; joint uses are investigational.
- Can you take Bivalirudin and Pentosan Polysulfate together?
- Some users combine peptides within a single protocol, but stacking Bivalirudin and Pentosan Polysulfate has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Bivalirudin or Pentosan Polysulfate FDA-approved?
- Bivalirudin is FDA-approved for one or more indications. Pentosan Polysulfate is FDA-approved for one or more indications.
Read the full articles
- Bivalirudin — full monograph: mechanism, research, dosing & references
- Pentosan Polysulfate — full monograph: mechanism, research, dosing & references